Cell Culture Industry Data Book - Cell Culture, Cell Culture Media, 3D Cell Culture, Primary Cell Culture Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
- Published Date: Feb, 2023
- Report ID: sector-report-00141
- Format: Electronic (PDF)
- Number of Pages: 0
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List Of Abbreviations
Chapter 2 Market Definitions
- 2.1 Definitions
Chapter 3 Executive Summary
- 3.1 Market Summary
Chapter 4 Global Cell Culture Industry Variables, Trends, & Scope
- 4.1 Cell Culture Industry Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration And Growth Prospect Mapping
- 4.3 Regulatory Framework
- 4.4 Market Driver Analysis
- 4.4.1 Expansion in the scope of cell culture technology
- 4.4.2 Demand for biopharmaceuticals, artificial organs & vaccine production
- 4.4.3 Demand for serum-free, specialty and customized media
- 4.4.4 Expansion of biosimilars business
- 4.4.5 Increase in demand for stem cell therapy and regenerative medicine
- 4.4.6 Rising demand for organ transplantation & tissue engineering
- 4.4.7 Technological advancements in scaffold-free technology
- 4.4.8 Rise in investments and R&D funding for cell-based research
- 4.4.9 Rising usage of primary cell culture products in in-vitro testing and drug screening
- 4.4.10 Rising incidence of cancer and other chronic diseases
- 4.4.11 Advancements in genetic engineering protocols
- 4.4.12 Rise in research funding for functional biology and research
- 4.5 Market Restraint Analysis
- 4.5.1 Stringent regulatory guidelines
- 4.5.2 Scalability issues
- 4.5.3 Ethical issues concerning the use of animal-derived products
- 4.5.4 High cost associated with implementation
- 4.6 Value Chain Analysis
- 4.6.1 Value Chain Analysis/Route To Market
- 4.7 Consumer Behavior Analysis
- 4.8 Major Deals and Strategic Alliances Analysis
- 4.8.1 New product launch
- 4.8.1.1 Mergers and acquisitions
- 4.8.1.2 Expansion
- 4.8.1.3 Partnerships
- 4.8.1.4 Marketing & promotions
- 4.8.1.5 Market entry strategies
- 4.8.2 Mergers And Deals
- 4.9 Cell Culture Market Analysis Tools
- 4.9.1 Industry Analysis - Porter’s
- 4.9.2 SWOT Analysis, By PEST
- 4.10 Cell Culture Media Market Analysis Tools
- 4.10.1 Industry Analysis - Porter’s
- 4.10.2 SWOT Analysis, By PEST
- 4.11 3D Cell Culture Market Analysis Tools
- 4.11.1 Industry Analysis - Porter’s
- 4.11.2 SWOT Analysis, By PEST
- 4.12 Primary Cell Culture Market Analysis Tools
- 4.12.1 Industry Analysis - Porter’s
- 4.12.2 SWOT Analysis, By PEST
Chapter 5 Cell Culture Market - Segment Analysis, by Consumables, 2018 - 2030 (USD Million)
- 5.1 Cell Culture Market: Consumables Movement Analysis
- 5.2 Media
- 5.2.1 Media market, 2018 - 2030 (USD Million)
- 5.3 Sera
- 5.3.1 Sera market, 2018 - 2030 (USD Million)
- 5.3.2 Fetal bovine serum
- 5.3.2.1 Fetal bovine serum market, 2018 - 2030 (USD Million)
- 5.3.3 Other animal serum
- 5.3.3.1 Other animal serum market, 2018 - 2030 (USD Million)
- 5.4 Reagents
- 5.4.1 Reagents market, 2018 - 2030 (USD Million)
- 5.4.2 Albumin
- 5.4.2.1 Albumin market, 2018 - 2030 (USD Million)
- 5.4.3 Other
- 5.4.3.1 Other market, 2018 - 2030 (USD Million)
Chapter 6 Cell Culture Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 6.1 Cell Culture Market: Product Movement Analysis
- 6.2 Culture Systems
- 6.2.1 Culture systems market, 2018 - 2030 (USD Million)
- 6.3 Incubators
- 6.3.1 Incubators market, 2018 - 2030 (USD Million)
- 6.4 Centrifuges
- 6.4.1 Centrifuges market, 2018 - 2030 (USD Million)
- 6.5 Cryostorage equipment
- 6.5.1 Cryostorage equipment market, 2018 - 2030 (USD Million)
- 6.6 Biosafety equipment
- 6.6.1 Biosafety equipment market, 2018 - 2030 (USD Million)
- 6.7 Pipetting instruments
- 6.7.1 Pipetting instruments market, 2018 - 2030 (USD Million)
Chapter 7 Cell Culture Media Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 7.1 Cell Culture Media Market: Product Movement Analysis
- 7.2 Serum-free Media
- 7.2.1 Serum-free media market, 2018 - 2030 (USD Million)
- 7.2.2 CHO Media
- 7.2.2.1 CHO media market, 2018 - 2030 (USD Million)
- 7.2.3 BHK Medium
- 7.2.3.1 BHK medium market, 2018 - 2030 (USD Million)
- 7.2.4 Vero Medium
- 7.2.4.1 Vero medium market, 2018 - 2030 (USD Million)
- 7.2.5 HEK 293 Media
- 7.2.5.1 HEK 293 media market, 2018 - 2030 (USD Million)
- 7.2.6 Other Serum-free Media
- 7.2.6.1 Other serum-free media market, 2018 - 2030 (USD Million)
- 7.3 Classical Media
- 7.3.1 Classical media market, 2018 - 2030 (USD Million)
- 7.4 Stem Cell Culture Media
- 7.4.1 Stem cell culture media market, 2018 - 2030 (USD Million)
- 7.5 Specialty Media
- 7.5.1 Specialty media market, 2018 - 2030 (USD Million)
- 7.6 Chemically Defined Media
- 7.6.1 Chemically defined media market, 2018 - 2030 (USD Million)
- 7.7 Others
- 7.7.1 Others market, 2018 - 2030 (USD Million)
Chapter 8 Cell Culture Media Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 8.1 Cell Culture Media Market: Application Movement Analysis
- 8.2 Biopharmaceutical Production
- 8.2.1 Biopharmaceutical production market, 2018 - 2030 (USD Million)
- 8.2.2 Monoclonal antibodies
- 8.2.2.1 Monoclonal antibodies market, 2018 - 2030 (USD Million)
- 8.2.3 Vaccines production
- 8.2.3.1 Vaccines production market, 2018 - 2030 (USD Million)
- 8.2.4 Other therapeutic proteins
- 8.2.4.1 Other therapeutic proteins market, 2018 - 2030 (USD Million)
- 8.3 Diagnostics
- 8.3.1 Diagnostics market, 2018 - 2030 (USD Million)
- 8.4 Drug screening and development
- 8.4.1 Drug screening and development market, 2018 - 2030 (USD Million)
- 8.5 Tissue Engineering and Regenerative Medicine
- 8.5.1 Tissue engineering and regenerative medicine market, 2018 - 2030 (USD Million)
- 8.5.2 Cell and gene therapy
- 8.5.2.1 Cell and gene therapy market, 2018 - 2030 (USD Million)
- 8.5.3 Other tissue engineering and regenerative medicine applications
- 8.5.3.1 Other tissue engineering and regenerative medicine applications market, 2018 - 2030 (USD Million)
- 8.6 Other Applications
- 8.6.1 Other applications market, 2018 - 2030 (USD Million)
Chapter 9 Cell Culture Media Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 9.1 Cell Culture Media Market: Type Movement Analysis
- 9.2 Liquid Media
- 9.2.1 Liquid media market, 2018 - 2030 (USD Million)
- 9.3 Semi-solid and Solid Media
- 9.3.1 Semi-solid and solid media market, 2018 - 2030 (USD Million)
Chapter 10 Cell Culture Media Market - Segment Analysis, by End user, 2018 - 2030 (USD Million)
- 10.1 Cell Culture Media Market: End user Movement Analysis
- 10.2 Pharmaceutical and Biotechnology Companies
- 10.2.1 Pharmaceutical and biotechnology companies market, 2018 - 2030 (USD Million)
- 10.3 Hospitals and Diagnostic Laboratories
- 10.3.1 Hospitals and diagnostic laboratories market, 2018 - 2030 (USD Million)
- 10.4 Research and Academic Institutes
- 10.4.1 Research and academic institutes market, 2018 - 2030 (USD Million)
- 10.5 Others
- 10.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 11 3D Cell Culture Market - Segment Analysis, by Technology, 2018 - 2030 (USD Million)
- 11.1 3D Cell Culture Market: Technology Movement Analysis
- 11.2 Scaffold based
- 11.2.1 Scaffold based market, 2018 - 2030 (USD Million)
- 11.2.2 Hydrogels
- 11.2.2.1 Hydrogels market, 2018 - 2030 (USD Million)
- 11.2.3 Polymeric scaffolds
- 11.2.3.1 Polymeric scaffolds market, 2018 - 2030 (USD Million)
- 11.2.4 Micropatterned surface microplates
- 11.2.4.1 Micropatterned surface microplates market, 2018 - 2030 (USD Million)
- 11.2.5 Nanofiber based scaffolds
- 11.2.5.1 Nanofiber based scaffolds market, 2018 - 2030 (USD Million)
- 11.3 Scaffold free
- 11.3.1 Scaffold free market, 2018 - 2030 (USD Million)
- 11.3.2 Hanging drop microplates
- 11.3.2.1 Hanging drop microplates market, 2018 - 2030 (USD Million)
- 11.3.3 Spheroid microplates containing Ultra-Low Attachment (ULA) coating
- 11.3.3.1 Spheroid microplates containing Ultra-Low Attachment (ULA) coating market, 2018 - 2030 (USD Million)
- 11.3.4 Microfluidic 3D cell culture
- 11.3.4.1 Microfluidic 3D cell culture market, 2018 - 2030 (USD Million)
- 11.3.5 Magnetic levitations & 3D bioprinting
- 11.3.5.1 Magnetic levitations & 3D bioprinting market, 2018 - 2030 (USD Million)
- 11.4 3D Bioreactors
- 11.4.1 3D bioreactors market, 2018 - 2030 (USD Million)
Chapter 12 3D Cell Culture Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 12.1 3D Cell Culture Market: Application Movement Analysis
- 12.2 Cancer
- 12.2.1 Cancer market, 2018 - 2030 (USD Million)
- 12.3 Tissue engineering & immunohistochemistry
- 12.3.1 Tissue engineering & immunohistochemistry market, 2018 - 2030 (USD Million)
- 12.4 Drug development
- 12.4.1 Drug development market, 2018 - 2030 (USD Million)
- 12.5 Stem cell research
- 12.5.1 Stem cell research market, 2018 - 2030 (USD Million)
- 12.6 Others
- 12.6.1 Others market, 2018 - 2030 (USD Million)
Chapter 13 3D Cell Culture Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
- 13.1 3D Cell Culture Market: End-use Movement Analysis
- 13.2 Biotechnology and pharmaceutical industries
- 13.2.1 Biotechnology and pharmaceutical industries market, 2018 - 2030 (USD Million)
- 13.3 Research laboratories and institutes
- 13.3.1 Research laboratories and institutes market, 2018 - 2030 (USD Million)
- 13.4 Hospitals and diagnostic centers
- 13.4.1 Hospitals and diagnostic centers market, 2018 - 2030 (USD Million)
- 13.5 Others
- 13.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 14 Primary Cell Culture Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 14.1 Primary Cell Culture Market: Product Movement Analysis
- 14.2 Primary Cells
- 14.2.1 Primary cells market, 2018 - 2030 (USD Million)
- 14.2.2 Fat cells
- 14.2.2.1 Fat cells market, 2018 - 2030 (USD Million)
- 14.2.3 Blood cells
- 14.2.3.1 Blood cells market, 2018 - 2030 (USD Million)
- 14.2.4 Nerve cells
- 14.2.4.1 Nerve cells market, 2018 - 2030 (USD Million)
- 14.2.5 Bone cells
- 14.2.5.1 Bone cells market, 2018 - 2030 (USD Million)
- 14.2.6 Endothelial cells
- 14.2.6.1 Endothelial cells market, 2018 - 2030 (USD Million)
- 14.2.7 Skin cells
- 14.2.7.1 Skin cells market, 2018 - 2030 (USD Million)
- 14.2.8 Muscle cells
- 14.2.8.1 Muscle cells market, 2018 - 2030 (USD Million)
- 14.2.9 Stem cells
- 14.2.9.1 Stem cells market, 2018 - 2030 (USD Million)
- 14.2.10 Others
- 14.2.10.1 Others market, 2018 - 2030 (USD Million)
- 14.3 Reagents and Supplements
- 14.3.1 Reagents and supplements market, 2018 - 2030 (USD Million)
- 14.3.2 Attachment solutions
- 14.3.2.1 Attachment solutions market, 2018 - 2030 (USD Million)
- 14.3.3 Buffers and salts
- 14.3.3.1 Buffers and salts market, 2018 - 2030 (USD Million)
- 14.3.4 Freezing media
- 14.3.4.1 Freezing media market, 2018 - 2030 (USD Million)
- 14.3.5 Sera
- 14.3.5.1 Sera market, 2018 - 2030 (USD Million)
- 14.3.6 Growth factors and cytokines
- 14.3.6.1 Growth factors and cytokines market, 2018 - 2030 (USD Million)
- 14.3.7 Others
- 14.3.7.1 Others market, 2018 - 2030 (USD Million)
- 14.4 Media
- 14.4.1 Media market, 2018 - 2030 (USD Million)
Chapter 15 Primary Cell Culture Market - Segment Analysis, by Separation Methods, 2018 - 2030 (USD Million)
- 15.1 Primary Cell Culture Market: Separation Methods Movement Analysis
- 15.2 Explant Method
- 15.2.1 Explant method market, 2018 - 2030 (USD Million)
- 15.3 Enzymatic degradation
- 15.3.1 Enzymatic degradation market, 2018 - 2030 (USD Million)
- 15.3.2 Trypsin
- 15.3.2.1 Trypsin market, 2018 - 2030 (USD Million)
- 15.3.3 Collagenase
- 15.3.3.1 Collagenase market, 2018 - 2030 (USD Million)
- 15.3.4 Protease
- 15.3.4.1 Protease market, 2018 - 2030 (USD Million)
- 15.3.5 Pronase
- 15.3.5.1 Pronase market, 2018 - 2030 (USD Million)
- 15.3.6 Dispase
- 15.3.6.1 Dispase market, 2018 - 2030 (USD Million)
- 15.3.7 Hyaluronidase
- 15.3.7.1 Hyaluronidase market, 2018 - 2030 (USD Million)
- 15.3.8 Neuraminidase
- 15.3.8.1 Neuraminidase market, 2018 - 2030 (USD Million)
- 15.3.9 Elastase
- 15.3.9.1 Elastase market, 2018 - 2030 (USD Million)
- 15.3.10 DNase
- 15.3.10.1 DNase market, 2018 - 2030 (USD Million)
- 15.3.11 Neuraminidase
- 15.3.11.1 Neuraminidase market, 2018 - 2030 (USD Million)
- 15.3.12 Elastase
- 15.3.12.1 Elastase market, 2018 - 2030 (USD Million)
- 15.3.14 DNase
- 15.3.14.1 DNase market, 2018 - 2030 (USD Million)
- 15.3.14 Papain
- 15.3.14.1 Papain market, 2018 - 2030 (USD Million)
- 15.3.15 Accutase
- 15.3.15.1 Accutase market, 2018 - 2030 (USD Million)
- 15.3.16 Others
- 15.3.16.1 Others market, 2018 - 2030 (USD Million)
- 15.4 Mechanical Separation
- 15.4.1 Mechanical separation market, 2018 - 2030 (USD Million)
- 15.5 Others
- 15.5.1 Others market, 2018 - 2030 (USD Million)
Chapter 16 Primary Cell Culture Market - Segment Analysis, by Cell Type, 2018 - 2030 (USD Million)
- 16.1 Primary Cell Culture Market: Cell Type Movement Analysis
- 16.2 Animal Cells
- 16.2.1 Animal cells market, 2018 - 2030 (USD Million)
- 16.3 Human Cells
- 16.3.1 Human cells market, 2018 - 2030 (USD Million)
Chapter 17 Primary Cell Culture Market - Segment Analysis, by Application, 2018 - 2030 (USD Million)
- 17.1 Primary Cell Culture Market: Application Movement Analysis
- 17.2 Tissue Culture & Tissue Engineering
- 17.2.1 Tissue culture & tissue engineering market, 2018 - 2030 (USD Million)
- 17.3 Vaccine Production
- 17.3.1 Vaccine production market, 2018 - 2030 (USD Million)
- 17.4 Gene Therapy and Regenerative Medicine
- 17.4.1 Gene therapy and regenerative medicine market, 2018 - 2030 (USD Million)
- 17.5 Toxicity Testing and Drug Screening
- 17.5.1 Toxicity testing and drug screening market, 2018 - 2030 (USD Million)
- 17.6 Cancer Research
- 17.6.1 Cancer research market, 2018 - 2030 (USD Million)
- 17.7 Tissue Culture & Tissue Engineering
- 17.7.1 Tissue culture & tissue engineering market, 2018 - 2030 (USD Million)
- 17.8 Model System
- 17.8.1 Model system market, 2018 - 2030 (USD Million)
- 17.9 Virology
- 17.9.1 Virology market, 2018 - 2030 (USD Million)
- 17.10 Prenatal Diagnosis
- 17.10.1 Prenatal diagnosis market, 2018 - 2030 (USD Million)
- 17.11 Stem Cell Therapy
- 17.11.1 Stem cell therapy market, 2018 - 2030 (USD Million)
- 17.12 Others
- 17.12.1 Others market, 2018 - 2030 (USD Million)
Chapter 18 Cell Culture Industry - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 18.1 Cell Culture Industry: Regional Movement Analysis
- 18.2 North America
- 18.2.1 North America
- 18.2.2 North America Cell Culture Market, 2018 - 2030 (USD Million)
- 18.2.3 U.S.
- 18.2.3.1 U.S. Cell Culture Market, 2018 - 2030 (USD Million)
- 18.2.4 Canada
- 18.2.4.1 Canada Cell Culture Market, 2018 - 2030 (USD Million)
- 18.3 Europe
- 18.3.1 Europe
- 18.3.2 Europe Cell Culture Market, 2018 - 2030 (USD Million)
- 18.3.3 UK
- 18.3.3.1 UK Cell Culture Market, 2018 - 2030 (USD Million)
- 18.3.4 Germany
- 18.3.4.1 Germany Cell Culture Market, 2018 - 2030 (USD Million)
- 18.3.5 Spain
- 18.3.5.1 Spain Cell Culture Market, 2018 - 2030 (USD Million)
- 18.3.6 France
- 18.3.6.1 France Cell Culture Market, 2018 - 2030 (USD Million)
- 18.3.7 Italy
- 18.3.7.1 Italy Cell Culture Market, 2018 - 2030 (USD Million)
- 18.4 Asia Pacific
- 18.4.1 Asia Pacific
- 18.4.2 Asia Pacific Cell Culture Market, 2018 - 2030 (USD Million)
- 18.4.3 Japan
- 18.4.3.1 Japan Cell Culture Market, 2018 - 2030 (USD Million)
- 18.4.4 China
- 18.4.4.1 China Cell Culture Market, 2018 - 2030 (USD Million)
- 18.4.5 India
- 18.4.5.1 India Cell Culture Market, 2018 - 2030 (USD Million)
- 18.4.6 South Korea
- 18.4.6.1 South Korea Cell Culture Market, 2018 - 2030 (USD Million)
- 18.4.7 Australia
- 18.4.7.1 Australia Cell Culture Market, 2018 - 2030 (USD Million)
- 18.5 Latin America
- 18.5.1 Latin America
- 18.5.2 Latin America Cell Culture Market, 2018 - 2030 (USD Million)
- 18.5.3 Brazil
- 18.5.3.1 Brazil Cell Culture Market, 2018 - 2030 (USD Million)
- 18.5.4 Mexico
- 18.5.4.1 Mexico Cell Culture Market, 2018 - 2030 (USD Million)
- 18.5.5 Argentina
- 18.5.5.1 Argentina Cell Culture Market, 2018 - 2030 (USD Million)
- 18.6 Middle East and Africa
- 18.6.1 Middle East & Africa, SWOT Analysis
- 18.6.2 Middle-East And Africa Cell Culture Market, 2018 - 2030 (USD Million)
- 18.6.3 South Africa
- 18.6.3.1 South Africa Cell Culture Market, 2018 - 2030 (USD Million)
- 18.6.4 UAE
- 18.6.4.1 UAE Cell Culture Market, 2018 - 2030 (USD Million)
- 18.6.5 Saudi Arabia
- 18.6.5.1 Saudi Arabia Cell Culture Market, 2018 - 2030 (USD Million)
Chapter 19 Competitive Analysis
- 19.1 Recent Developments & Impact Analysis, By Key Market Participants
- 19.1.1 Ansoff Matrix
- 19.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
- 19.1.3 Innovators
- 19.2 Vendor Landscape
- 19.2.1 List Of Key Distributors And Channel Partners
- 19.2.2 Global Cell Culture Industry: Key Company Market Share Analysis, 2021
- 19.3 Public Companies
- 19.3.1 Company Market Position Analysis
- 19.3.2 Competitive Dashboard Analysis
- 19.3.3 Strategic Framework
- 19.4 Private Companies
- 19.4.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
- 19.4.2 Regional Network Map
- 19.5 Company Profiles
- 19.5.1 DANAHER CORPORATION
- 19.5.1.1 Company Overview
- 19.5.1.1.1 Cytiva
- 19.5.1.2 Financial Performance
- 19.5.1.3 Product Benchmarking
- 19.5.1.4 Strategic Initiatives
- 19.5.2 SARTORIUS AG
- 19.5.2.1 Company Overview
- 19.5.2.2 Financial Performance
- 19.5.2.3 Product Benchmarking
- 19.5.2.4 Strategic Initiatives
- 19.5.3 THERMO FISHER SCIENTIFIC, INC.
- 19.5.3.1 Company Overview
- 19.5.3.2 Financial Performance
- 19.5.3.3 Product Benchmarking
- 19.5.3.4 Strategic Initiatives
- 19.5.4 BIO-RAD LABORATORIES, INC.
- 19.5.4.1 Company Overview
- 19.5.4.2 Financial Performance
- 19.5.4.3 Product Benchmarking
- 19.5.4.4 Strategic Initiatives
- 19.5.5 MERCK KGAA
- 19.5.5.1 Company Overview
- 19.5.5.2 Financial Performance
- 19.5.5.3 Product Benchmarking
- 19.5.5.4 Strategic Initiatives
- 19.5.6 EPPENDORF AG
- 19.5.6.1 Company Overview
- 19.5.6.2 Financial Performance
- 19.5.6.3 Product Benchmarking
- 18.5.6.4 Strategic Initiatives
- 19.5.7 BECTON, DICKINSON AND COMPANY
- 19.5.7.1 Company Overview
- 19.5.7.2 Financial Performance
- 19.5.7.3 Product Benchmarking
- 19.5.7.4 Strategic Initiatives
- 19.5.8 VWR INTERNATIONAL, LLC
- 19.5.8.1 Company Overview
- 19.5.8.2 Financial Performance
- 19.5.8.3 Product Benchmarking
- 19.5.8.4 Strategic Initiatives
- 19.5.9 PROMOCELL GMBH
- 19.5.9.1 Company Overview
- 19.5.9.2 Financial Performance
- 19.5.9.3 Product Benchmarking
- 19.5.9.4 Strategic Initiatives
- 19.5.10 BIO-TECHNE CORPORATION
- 19.5.10.1 Company Overview
- 19.5.10.2 Financial Performance
- 19.5.10.3 Product Benchmarking
- 19.5.10.4 Strategic Initiatives
- 19.5.11 BIOSPHERIX, LTD.
- 19.5.11.1 Company Overview
- 19.5.11.2 Financial Performance
- 19.5.11.3 Product Benchmarking
- 19.5.11.4 Strategic Initiatives
- 19.5.12 FUJIFILM IRVINE SCIENTIFIC, INC.
- 19.5.12.1 Company Overview
- 19.5.12.2 Financial Performance
- 19.5.12.3 Product Benchmarking
- 19.5.12.4 Strategic Initiatives
- 19.5.13 LONZA GROUP AG
- 19.5.13.1 Company Overview
- 19.5.13.2 Financial Performance
- 19.5.13.3 Product Benchmarking
- 19.5.13.4 Strategic Initiatives
- 19.5.14 INVIVOGEN
- 19.5.14.1 Company Overview
- 19.5.14.2 Financial Performance
- 19.5.14.3 Product Benchmarking
- 19.5.14.4 Strategic Initiatives
- 19.5.15 STEMCELL TECHNOLOGIES INC.
- 19.5.15.1 Company Overview
- 19.5.15.2 Financial Performance
- 19.5.15.3 Product Benchmarking
- 19.5.15.4 Strategic Initiatives
- 19.5.16 CELL BIOLOGICS, INC.
- 19.5.16.1 Company Overview
- 19.5.16.2 Financial Performance
- 19.5.16.3 Product Benchmarking
- 19.5.16.4 Strategic Initiatives
- 19.5.17 GREINER BIO ONE INTERNATIONAL GMBH
- 19.5.17.1 Company Overview
- 19.5.17.2 Financial Performance
- 19.5.17.3 Product Benchmarking
- 19.5.17.4 Strategic Initiatives
- 19.5.18 CORNING, INC.
- 19.5.18.1 Company Overview
- 19.5.18.2 Financial Performance
- 19.5.18.3 Product Benchmarking
- 19.5.18.4 Strategic Initiatives
- 19.5.19 3D BIOMATRIX
- 19.5.19.1 Company Overview
- 19.5.19.2 Financial Performance
- 19.5.19.3 Product Benchmarking
- 19.5.19.4 Strategic Initiatives
- 19.5.20 AVANTOR PERFORMANCE MATERIALS, LLC
- 19.5.20.1 Company Overview
- 19.5.20.2 Financial Performance
- 19.5.20.3 Product Benchmarking
- 19.5.20.4 Strategic Initiatives
- 19.5.21 TECAN TRADING AG
- 19.5.21.1 Company Overview
- 19.5.21.2 Financial Performance
- 19.5.21.3 Product Benchmarking
- 19.5.21.4 Strategic Initiatives
- 19.5.22 3D BIOTEK LLC
- 19.5.22.1 Company Overview
- 19.5.22.2 Financial Performance
- 19.5.22.3 Product Benchmarking
- 19.5.22.4 Strategic Initiatives
- 19.5.23 GLOBAL CELL SOLUTIONS, INC.
- 19.5.23.1 Company Overview
- 19.5.23.2 Financial Performance
- 19.5.23.3 Product Benchmarking
- 19.5.23.4 Strategic Initiatives
- 19.5.24 INSPHERO
- 19.5.24.1 Company Overview
- 19.5.24.2 Financial Performance
- 19.5.24.3 Product Benchmarking
- 19.5.24.4 Strategic Initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.